HIV-1 Vpu's lipid raft association is dispensable for counteraction of the particle release restriction imposed by CD317/Tetherin

Virology

Volumn 424, Issue 1, 2012, Pages 33-44

  Fritz, Joëlle V ^a   Tibroni, Nadine ^a   Keppler, Oliver T ^a   Fackler, Oliver T ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

CD317; CRAC motif; DRM; HIV 1 release; Lipid rafts; Vpu

Indexed keywords

CD137 ANTIGEN; CHOLESTEROL; PROTEIN; TYROSINE; VALINE;

AMINO ACID ANALYSIS; AMINO ACID SUBSTITUTION; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE MUTATION; GOLGI COMPLEX; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LIPID RAFT; MUTAGENESIS; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; REGULATOR GENE; VIRUS PARTICLE; VIRUS RELEASE; WILD TYPE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANTIGENS, CD; CELL LINE; CELL MEMBRANE; GPI-LINKED PROTEINS; HIV INFECTIONS; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; MEMBRANE LIPIDS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; SEQUENCE ALIGNMENT; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRUS RELEASE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84856223412     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.12.008     Document Type: Article

References (60)

1. Andrew A.J., Miyagi E., Strebel K. Differential effects of human immunodeficiency virus type 1 Vpu on the stability of BST-2/Tetherin. J. Virol. 2011, 85:2611-2619.
2. Banning C., Votteler J., Hoffmann D., Koppensteiner H., Warmer M., Reimer R., Kirchhoff F., Schubert U., Hauber J., Schindler M. A flow cytometry-based FRET assay to identify and analyse protein-protein interactions in living cells. PLoS One 2010, 5:e9344.
3. Browman D.T., Resek M.E., Zajchowski L.D., Robbins S.M. Erlin-1 and erlin-2 are novel members of the prohibitin family of proteins that define lipid-raft-like domains of the ER. J. Cell Sci. 2006, 119:3149-3160.
4. Brown D.A., Rose J.K. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 1992, 68:533-544.
5. Dube M., Roy B.B., Guiot-Guillain P., Mercier J., Binette J., Leung G., Cohen E.A. Suppression of Tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network. J. Virol. 2009, 83:4574-4590.
6. Dube M., Roy B.B., Guiot-Guillain P., Binette J., Mercier J., Chiasson A., Cohen E.A. Antagonism of Tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment. PLoS Pathog. 2010, 6:e1000856.
7. Erikson E., Adam T., Schmidt S., Lehmann-Koch J., Over B., Goffinet C., Harter C., Bekeredjian-Ding I., Sertel S., Lasitschka F., Keppler O.T. In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/Tetherin in humans. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:13688-13693.
8. Giese S.I., Woerz I., Homann S., Tibroni N., Geyer M., Fackler O.T. Specific and distinct determinants mediate membrane binding and lipid raft incorporation of HIV-1(SF2) Nef. Virology 2006, 355:175-191.
9. Goffinet C., Allespach I., Homann S., Tervo H.M., Habermann A., Rupp D., Oberbremer L., Kern C., Tibroni N., Welsch S., Krijnse-Locker J., Banting G., Krausslich H.G., Fackler O.T., Keppler O.T. HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor. Cell Host Microbe 2009, 5:285-297.
10. Goffinet C., Homann S., Ambiel I., Tibroni N., Rupp D., Keppler O.T., Fackler O.T. Antagonism of CD317 restriction of human immunodeficiency virus type 1 (HIV-1) particle release and depletion of CD317 are separable activities of HIV-1 Vpu. J. Virol. 2010, 84:4089-4094.
11. Gupta R.K., Hue S., Schaller T., Verschoor E., Pillay D., Towers G.J. Mutation of a single residue renders human Tetherin resistant to HIV-1 Vpu-mediated depletion. PLoS Pathog. 2009, 5:e1000443.
12. Hauser H., Lopez L.A., Yang S.J., Oldenburg J.E., Exline C.M., Guatelli J.C., Cannon P.M. HIV-1 Vpu and HIV-2 Env counteract BST-2/Tetherin by sequestration in a perinuclear compartment. Retrovirology 2010, 7:51.
13. Hinz A., Miguet N., Natrajan G., Usami Y., Yamanaka H., Renesto P., Hartlieb B., McCarthy A.A., Simorre J.P., Gottlinger H., Weissenhorn W. Structural basis of HIV-1 tethering to membranes by the BST-2/Tetherin ectodomain. Cell Host Microbe 2010, 7:314-323.
14. Holm K., Weclewicz K., Hewson R., Suomalainen M. Human immunodeficiency virus type 1 assembly and lipid rafts: Pr55(gag) associates with membrane domains that are largely resistant to Brij98 but sensitive to Triton X-100. J. Virol. 2003, 77:4805-4817.
15. Ishikawa J., Kaisho T., Tomizawa H., Lee B.O., Kobune Y., Inazawa J., Oritani K., Itoh M., Ochi T., Ishihara K., et al. Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cell growth. Genomics 1995, 26:527-534.
16. Iwabu Y., Fujita H., Kinomoto M., Kaneko K., Ishizaka Y., Tanaka Y., Sata T., Tokunaga K. HIV-1 accessory protein Vpu internalizes cell-surface BST-2/Tetherin through transmembrane interactions leading to lysosomes. J. Biol. Chem. 2009, 284:35060-35072.
17. Jouvenet N., Neil S.J., Zhadina M., Zang T., Kratovac Z., Lee Y., McNatt M., Hatziioannou T., Bieniasz P.D. Broad-spectrum inhibition of retroviral and filoviral particle release by Tetherin. J. Virol. 2009, 83:1837-1844.
18. Kaletsky R.L., Francica J.R., Agrawal-Gamse C., Bates P. Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:2886-2891.
19. Keppler O.T., Allespach I., Schuller L., Fenard D., Greene W.C., Fackler O.T. Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor Nef. J. Virol. 2005, 79:1655-1665.
20. Kobayashi T., Ode H., Yoshida T., Sato K., Gee P., Yamamoto S.P., Ebina H., Strebel K., Sato H., Koyanagi Y. Identification of amino acids in the human Tetherin transmembrane domain responsible for HIV-1 Vpu interaction and susceptibility. J. Virol. 2011, 85:932-945.
21. Krautkramer E., Giese S.I., Gasteier J.E., Muranyi W., Fackler O.T. Human immunodeficiency virus type 1 Nef activates p21-activated kinase via recruitment into lipid rafts. J. Virol. 2004, 78:4085-4097.
22. Kuhl B.D., Sloan R.D., Donahue D.A., Liang C., Wainberg M.A. Vpu-mediated Tetherin antagonism of ongoing HIV-1 infection in CD4(+) T-cells is not directly related to the extent of Tetherin cell surface downmodulation. Virology 2011, 417:353-361.
23. Kupzig S., Korolchuk V., Rollason R., Sugden A., Wilde A., Banting G. Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic 2003, 4:694-709.
24. Lau D., Kwan W., Guatelli J. Role of the endocytic pathway in the counteraction of BST-2 by human lentiviral pathogens. J. Virol. 2011, 85:9834-9846.
25. Li H., Papadopoulos V. Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology 1998, 139:4991-4997.
26. Li N., Mak A., Richards D.P., Naber C., Keller B.O., Li L., Shaw A.R. Monocyte lipid rafts contain proteins implicated in vesicular trafficking and phagosome formation. Proteomics 2003, 3:536-548.
27. Lindwasser O.W., Resh M.D. Myristoylation as a target for inhibiting HIV assembly: unsaturated fatty acids block viral budding. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:13037-13042.
28. Lingwood D., Simons K. Lipid rafts as a membrane-organizing principle. Science 2010, 327:46-50.
29. Mangeat B., Gers-Huber G., Lehmann M., Zufferey M., Luban J., Piguet V. HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation. PLoS Pathog. 2009, 5:e1000574.
30. Mansouri M., Viswanathan K., Douglas J.L., Hines J., Gustin J., Moses A.V., Fruh K. Molecular mechanism of BST2/Tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus. J. Virol. 2009, 83:9672-9681.
31. Masuyama N., Kuronita T., Tanaka R., Muto T., Hirota Y., Takigawa A., Fujita H., Aso Y., Amano J., Tanaka Y. HM1.24 is internalized from lipid rafts by clathrin-mediated endocytosis through interaction with alpha-adaptin. J. Biol. Chem. 2009, 284:15927-15941.
32. Michel N., Allespach I., Venzke S., Fackler O.T., Keppler O.T. The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4. Curr. Biol. 2005, 15:714-723.
33. Mitchell R.S., Katsura C., Skasko M.A., Fitzpatrick K., Lau D., Ruiz A., Stephens E.B., Margottin-Goguet F., Benarous R., Guatelli J.C. Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking. PLoS Pathog. 2009, 5:e1000450.
34. Miyagi E., Andrew A.J., Kao S., Strebel K. Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:2868-2873.
35. Morrow I.C., Parton R.G. Flotillins and the PHB domain protein family: rafts, worms and anaesthetics. Traffic 2005, 6:725-740.
36. Neil S.J., Zang T., Bieniasz P.D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008, 451:425-430.
37. Nguyen D.H., Hildreth J.E. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J. Virol. 2000, 74:3264-3272.
38. Nguyen K.L., Llano M., Akari H., Miyagi E., Poeschla E.M., Strebel K., Bour S. Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression. Virology 2004, 319:163-175.
39. Ono A., Freed E.O. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:13925-13930.
40. Pardieu C., Vigan R., Wilson S.J., Calvi A., Zang T., Bieniasz P., Kellam P., Towers G.J., Neil S.J. The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of Tetherin. PLoS Pathog. 2010, 6:e1000843.
41. Perez-Caballero D., Zang T., Ebrahimi A., McNatt M.W., Gregory D.A., Johnson M.C., Bieniasz P.D. Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 2009, 139:499-511.
42. Pfeiffer T., Pisch T., Devitt G., Holtkotte D., Bosch V. Effects of signal peptide exchange on HIV-1 glycoprotein expression and viral infectivity in mammalian cells. FEBS Lett. 2006, 580:3775-3778.
43. Radoshitzky S.R., Dong L., Chi X., Clester J.C., Retterer C., Spurgers K., Kuhn J.H., Sandwick S., Ruthel G., Kota K., Boltz D., Warren T., Kranzusch P.J., Whelan S.P., Bavari S. Infectious Lassa virus, but not filoviruses, is restricted by BST-2/Tetherin. J. Virol. 2010, 84:10569-10580.
44. Rauch S., Pulkkinen K., Saksela K., Fackler O.T. Human immunodeficiency virus type 1 Nef recruits the guanine exchange factor Vav1 via an unexpected interface into plasma membrane microdomains for association with p21-activated kinase 2 activity. J. Virol. 2008, 82:2918-2929.
45. Rollason R., Korolchuk V., Hamilton C., Schu P., Banting G. Clathrin-mediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine motif. J. Cell Sci. 2007, 120:3850-3858.
46. Rong L., Zhang J., Lu J., Pan Q., Lorgeoux R.P., Aloysius C., Guo F., Liu S.L., Wainberg M.A., Liang C. The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu. J. Virol. 2009, 83:7536-7546.
47. Ross T.M., Oran A.E., Cullen B.R. Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein. Curr. Biol. 1999, 9:613-621.
48. Ruiz A., Hill M.S., Schmitt K., Stephens E.B. Membrane raft association of the Vpu protein of human immunodeficiency virus type 1 correlates with enhanced virus release. Virology 2010, 408:89-102.
49. Sakuma T., Noda T., Urata S., Kawaoka Y., Yasuda J. Inhibition of Lassa and Marburg virus production by Tetherin. J. Virol. 2009, 83:2382-2385.
50. Schmidt S., Fritz J.V., Bitzegeio J., Fackler O.T., Keppler O.T. HIV-1 Vpu blocks recycling and biosynthetic transport of the intrinsic immunity factor CD317/Tetherin to overcome the virion release restriction. mBio 2011, 2:e00036-11.
51. Serra-Moreno R., Jia B., Breed M., Alvarez X., Evans D.T. Compensatory changes in the cytoplasmic tail of gp41 confer resistance to Tetherin/BST-2 in a pathogenic nef-deleted SIV. Cell Host Microbe 2011, 9:46-57.
52. Simons K., Ikonen E. Functional rafts in cell membranes. Nature 1997, 387:569-572.
53. Tervo H.M., Homann S., Ambiel I., Fritz J.V., Fackler O.T., Keppler O.T. beta-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release. Retrovirology 2011, 8:9.
54. Van Damme N., Goff D., Katsura C., Jorgenson R.L., Mitchell R., Johnson M.C., Stephens E.B., Guatelli J. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 2008, 3:245-252.
55. Vigan R., Neil S.J. Determinants of Tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein. J. Virol. 2010, 84:12958-12970.
56. Vishwanathan S.A., Thomas A., Brasseur R., Epand R.F., Hunter E., Epand R.M. Hydrophobic substitutions in the first residue of the CRAC segment of the gp41 protein of HIV. Biochemistry 2008, 47:124-130.
57. Weidner J.M., Jiang D., Pan X.B., Chang J., Block T.M., Guo J.T. Interferon-induced cell membrane proteins, IFITM3 and Tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J. Virol. 2010, 84:12646-12657.
58. Yang H., Wang J., Jia X., McNatt M.W., Zang T., Pan B., Meng W., Wang H.W., Bieniasz P.D., Xiong Y. Structural insight into the mechanisms of enveloped virus tethering by Tetherin. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:18428-18432.
59. Yondola M.A., Fernandes F., Belicha-Villanueva A., Uccelini M., Gao Q., Carter C., Palese P. Budding capability of the influenza virus neuraminidase can be modulated by Tetherin. J. Virol. 2011, 85:2480-2491.
60. Zheng Y.Z., Foster L.J. Biochemical and proteomic approaches for the study of membrane microdomains. J. Proteomics 2009, 72:12-22.